We also demonstrated expression of FAM159B in many tumour cell lines and tumour entities, with especially high levels in pituitary adenomas, medullary and anaplastic thyroid carcinomas, parathyroid adenomas, lung and ovarian carcinomas, lymphomas, and neuroendocrine tumours of various origins. Here, SHISAL2B is linked to neuroendocrine neoplasm.